Gsa Capital Partners LLP Standard Biotools Inc. Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$2.8 - $3.96 $284,183 - $401,916	-101,494 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.63 - $6.13 $209,048 - $353,020	57,589 Added 131.17%	101,494 $398,000
Q3 2021 Nov 12, 2021	BUY	$5.5 - $7.41 $241,477 - $325,336	43,905 New	43,905 $289,000
Q2 2021 Aug 05, 2021	SELL	$4.35 - $6.35 $460,456 - $672,160	-105,852 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$3.94 - $7.09 $251,797 - $453,107	63,908 Added 152.37%	105,852 $478,000
Q4 2020 Feb 03, 2021	SELL	$5.45 - $8.65 $223,226 - $354,295	-40,959 Reduced 49.41%	41,944 $252,000
Q3 2020 Nov 06, 2020	BUY	$4.34 - $11.43 $359,799 - $947,581	82,903 New	82,903 $616,000
Q2 2019 Aug 06, 2019	SELL	$11.49 - $14.17 $711,345 - $877,264	-61,910 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$8.47 - $14.36 $524,377 - $889,027	61,910 New	61,910 $823,000

144

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $134M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.